-Caveat Lector-

..............................................................

Forwarded from the New Paradigms Project [Not Necessarily Endorsed]:
From: Ian Goddard <[EMAIL PROTECTED]>
To: [EMAIL PROTECTED] <[EMAIL PROTECTED]>
Subject: DRUGGING KIDS: A New Agenda?
Date: Wednesday, December 08, 1999 5:58 AM


 (http://users.erols.com/igoddard/polyrisk.htm)

  LOOKING FOR "EARLY SCHIZOPHRENIA" IN CHILDREN

  MAY INCREASE RISK OF IATROGENIC POLYPHARMACY

  (c) 12/8/99 Ian Williams Goddard

  The New York Times (12/7/99) [1] reports that a possible
  new psychiatric diagnostic agenda for children may be to
  identify "early warning signs" of schizophrenia that are
  to be treated with antipsychotic drugs. Research funded
  in part by the drug company Eli Lilly is attempting to
  see if antipsychotic drugs can reduce the incidence of
  full-blown schizophrenia if given to "high-risk" subjects
  while they are still children. With the ability to cause
  permanent brain damage and disfiguring conditions such as
  tardive dyskinesia, antipsychotic drugs, also known as
  neuroleptics, are the most harmful psychiatric drugs. [2]

  Also of concern regarding an "early schizophrenic" focus
  in childhood diagnosis is that the drug Ritalin, which
  is being prescribed to millions of children, is known to
  produce symptoms that mimic schizophrenia. [3] One drug
  study even found that Ritalin "induces a psychopathology
  that seems to mimic schizophrenic psychosis more closely
  than that induced by amphetamines and cocaine." [4] About
  the ability of psychostimulants such as Ritalin to mimic
  symptoms of schizophrenia, Peter Breggin, M.D., states:

    "All of the stimulants, including Cylert, can cause
    psychoses that mimic schizophrenia... These drug-
    induced psychoses look so much like schizophrenia
    that a strong argument has been made that stimulant
    abuse sometimes causes 'chronic schizophrenia.'(43)" [5]

  Since doctors often prescribe multiple drugs (polypharmacy),
  and since an illness treated by one drug may be caused by
  another (iatrogenic polypharmacy), the potential exists that
  Ritalin-induced schizophrenia might be treated with even more
  dangerous mind-altering drugs. As Breggin observes: "Because
  Ritalin is promoted as relatively free of adverse effects,
  the development of a severe mental disturbance can be
  mistaken for the surfacing of further 'mental illness.'" [6]

  The potential for iatrogenic polypharmacy could arise as a
  result of any "early schizophrenia treatment" agenda unless
  all doctors are aware of all adverse effects of stimulants
  and are willing to take a child off them to see if symptoms
  subside before they risk prescribing potentially brain-
  damaging neuroleptics, and yet psychosis has been reported
  during withdrawal from long-term Ritalin use. [7] Chances
  are some doctors will drug first and ask questions later.

  Quoted below are excerpts from a study that found Ritalin
  produced a dose-dependent dysfunction in nonschizophrenics
  that "'mimics' schizophrenic psychopathology." The range of
  doses in the study intersects Ritalin's therapeutic range.
  The study used Ritalin to test a hypothesis about the nature
  of an on-set schizophrenic dysfunction. The fact that Ritalin
  (methylphenidate) was chosen reflects the fact that it is a
  drug of choice for modeling schizophrenic psychopathology.

   Here then are important excerpts from that study:

    ==================================================
    Archives of General Psychiatry (1988;45(9):827-32)
    ==================================================

     Methylphenidate-Induced Information Processing
     Dysfunction in Nonschizophrenic Patients

     David L. Braff, MD, Leighton Huey, MD

     Department of Psychiatry, University
     of California, San Diego, La Jolla 92093.

     "Schizophrenic patients have significant deficits
     in a wide range of attentional and information
     processing tasks. It is hypothesized that
     catecholamine (eg, dopamine) overactivity may
     induce and that antipsychotic medications may
     reverse these attentional deficits." ...

     "This experiment was designed to test whether
     systemic administration of the dopamine agonist
     methylphenidate hydrochloride [Ritalin], in
     nonschizophrenic patients, would induce an
     information processing dysfunction similar to
     the dysfunction typically seen in schizophrenic
     patients in the visual backward masking task."[8]

     "These results show that methylphenidate, which
     increases central catecholaminergic activity,
     induces dose-dependent deficits in information
     processing similar to those seen in schizophrenic
     patients. ...this experiment used a combination
     of psychophysical tasks and pharmacological
     probes and is a novel illustration of how
     stimulant challenges can induce the type of
     information processing dysfunction seen in
     schizophrenic spectrum patients." ...

     "...the higher dose of methylphenidate induced
     significantly more information processing
     disruption, indicating a dose-dependant effect
     that needs further investigation." [IAN: The
     low dose in this study was 0.5 mg/kg, the high
     dose was 1 mg/kg, oral. Typical therapeutic
     doses of Ritalin range from .3 to .7 mg/kg [9]]

     "...we assume that normal humans operate at
     a highly efficient threshold level for many
     attentional operations, so that even modest
     impairments of these critical functions can
     result in cognitive or symptomatic impairment.
     ... In this context, our drug treatment effect
     represents a striking, methylphenidate-induced
     impairment of the normal mechanisms by which
     information is processed in humans." ...

     "[M]ethylphenidate, possibly through its aminergic-
     enhancing properties, 'mimics' schizophrenic
     psychopathology by inducing specific, time-
     linked backward visual masking abnormalities."

   ===================================================
    STUDY ABSTRACT: http://www.ncbi.nlm.nih.gov/htbin-
    post/Entrez/query?uid=2901251&form=6&db=m&Dopt=b
   ===================================================
  _______________________________________________________
  [1] The New York Times: Doctors Try a Bold Move Against
  Schizophrenia. By Erica Goode, December 7, 1999.
  http://nytimes.com/library/national/science/health/120799hth-behavior-

  [2] Should the use of neuroleptics be severely limited?
  Peter Breggin, MD: http://breggin.com/neuroleptics.html

  [3] Studies cited showing Ritalin can mimic and increase
  schizophrenia: http://www.erols.com/igoddard/conyers.htm

  [4] Journal of Pharmacology and Experiment Therapeutics:
  Inhibition of methylphenidate-induced behaviors in rats:
  differences among neuroleptics. Koek W, Colpaert FC 1993
  Oct;267(1):181-91.

  [5] Talking Back To Ritalin. By Peter R. Breggin, MD.
  page 18. The reference cited in the Breggin quote is:
  Flaum M., & Schultz S. K. (1996) When does amphetamine-
  induced psychosis become schizophrenia? American Journal
  of Psychiatry. 153(6), 812-5.

  [6] Ibid., page 17. http://www.breggin.com/prbbooks.html

  [7] American Journal of Psychiatry: Depression and psychotic
  regression following prolonged methylphenidate use and
  withdrawal: case report. Rosenfeld AA. 1979 Feb;136(2):226-8.

  [8] On Visual Backwards Masking Paradigm Tasking:
  http://www.sci.sdsu.edu/CAL/cab.html#BackMask
  On Visual Masking Deficits In Schizophrenic Patients:
  http://www.appi.org/ajp/dec96/ajp12toc.html#AJPdec96-9

  [9] Typical Starting Dosage...of Some ADHD Medications
  http://lib-sh.lsumc.edu/fammed/intern/adhdmeds.html

  (Web posted: http://www.erols.com/igoddard/polyrisk.htm)

--------------------------------------------------------------
GODDARD'S JOURNAL: http://users.erols.com/igoddard/journal.htm
______________________________________________________________



  Forwarded for info and discussion from the New Paradigms Discussion List,
not necessarily endorsed by:
***********************************
Lloyd Miller, Research Director for A-albionic Research (POB 20273,
Ferndale, MI 48220), a ruling class/conspiracy research resource for the
entire political-ideological spectrum.  Quarterly journal, book sales,
rare/out-of-print searches, New Paradigms Discussion List, Weekly Up-date
Lists & E-text Archive of research, intelligence, catalogs, & resources.
 To Discuss Ideas:
  mailto:[EMAIL PROTECTED]      http://msen.com/~lloyd/
  For Ordering Info & Free Catalog:
   mailto:[EMAIL PROTECTED]    http://a-albionic.com/formaddress.html
  For Discussion List:
   mailto:[EMAIL PROTECTED]
   text in body:  subscribe prj <[EMAIL PROTECTED]>
 **FREE RARE BOOK SEARCH: <[EMAIL PROTECTED]> **
   Explore Our Archive:  <http://a-albionic.com/a-albionic.html>
Every Diet Has Failed!  What Can I do?
Click Below to "Ask Dr. Kathleen"!
http://www.radiantdiet.com/cgi-bin/slim/deliver.cgi?ask-1364
***********************************

DECLARATION & DISCLAIMER
==========
CTRL is a discussion and informational exchange list. Proselyzting propagandic
screeds are not allowed. Substance—not soapboxing!  These are sordid matters
and 'conspiracy theory', with its many half-truths, misdirections and outright
frauds is used politically  by different groups with major and minor effects
spread throughout the spectrum of time and thought. That being said, CTRL
gives no endorsement to the validity of posts, and always suggests to readers;
be wary of what you read. CTRL gives no credeence to Holocaust denial and
nazi's need not apply.

Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:
http://home.ease.lsoft.com/archives/CTRL.html

http:[EMAIL PROTECTED]/
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Reply via email to